Entasis Therapeutics

-$0.04 (-1.27%) Today

+$0.66 (+21.22%) As of 10:44 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ETTX and other ETFs, options, and stocks.

About ETTX

Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections.

CEO

Manoussos Perros

Employees

Headquarters

Waltham, Massachusetts

Founded

2015

ETTX Key Statistics

Market Cap

147.14M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

123.86K

High Today

$3.19

Low Today

$3.09

Open Price

$3.17

Volume

2.45M

52 Week High

$3.88

52 Week Low

$1.58

ETTX News

Simply Wall StOct 14

How Many Entasis Therapeutics Holdings Inc. Shares Do Institutions Own?

A look at the shareholders of Entasis Therapeutics Holdings Inc. ( ) can tell us which group is most powerful. Institutions often own shares in more established

ETTX Earnings

-$1.15

-$0.77

-$0.38

$0.00

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Expected Nov 4, After Hours

Why Robinhood?

Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections. View more

How Many Entasis Therapeutics Holdings Inc. Shares Do Institutions Own?

Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections.